Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DUL9K5
|
|||
Drug Name |
RTX-134
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Phenylketonuria [ICD-11: 5C50.0; ICD-10: E70, E70.1] | Phase 1 | [1] | |
Company |
Rubius Therapeutics
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04110496) A Phase 1b Open-Label Single Dose Safety, Tolerability, and Pharmacokinetics Study of RTX-134 in Adults With Phenylketonuria. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.